• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔内感染的手术及非手术治疗

Operative and nonoperative therapy of intraabdominal infections.

作者信息

Wittmann D H

机构信息

Dept. of Surgery, Medical College of Wisconsin, Milwaukee 53226, USA.

出版信息

Infection. 1998 Sep-Oct;26(5):335-41. doi: 10.1007/BF02962267.

DOI:10.1007/BF02962267
PMID:9795802
Abstract

The basic principles for treating intraabdominal infections are fourfold: (1) to obliterate the infectious source; (2) to purge bacteria and toxins; (3) to maintain organ system function and (4) to tame the inflammatory process. Operative and nonoperative treatment options are available. Operative therapy includes different strategies: (1) the standard operation; (2) advanced procedures to decompress the abdominal compartment syndrome and (3) percutaneous drainage of abscesses. Nonoperative management includes: (1) antibiotic therapy; (2) hemodynamic and pulmonary support; (3) nutrition and metabolic support; (4) detoxification support (including support of renal and hepatic function) and (5) inflammation modulating therapy. Standard operative management addresses the first two principles and has been shown to reduce mortality by more than 50%. A recent extensive series of studies reports mortality rates around 20%. Patients with an abdominal compartment syndrome (intraabdominal pressure over 25 torr) and patients with advanced disease and compounding risk factors best documented by high APACHE-II scores are candidates for more advanced operations. The mortality rate following abdominostomy (leaving the abdomen open) in 869 patients participating in 37 studies was 42%, when the abdomen was simply left open for decompression (open abdominostomy). When a mesh was used to cover the abdominal wound (mesh abdominostomy) 39% of 439 patients enrolled in 12 studies died. Patients who underwent staged abdominal repair (STAR abdominostomy) faired better. Of 385 patients in 11 studies 28% died. Data from antibiotic studies as well as from immunomodulating therapy are nonconclusive at this point with respect to reducing mortality in intraabdominal infection.

摘要

治疗腹腔内感染的基本原则有四条

(1)消除感染源;(2)清除细菌和毒素;(3)维持器官系统功能;(4)控制炎症过程。有手术和非手术两种治疗选择。手术治疗包括不同策略:(1)标准手术;(2)用于减压腹腔间隔综合征的进阶手术;(3)经皮脓肿引流。非手术治疗包括:(1)抗生素治疗;(2)血流动力学和肺部支持;(3)营养和代谢支持;(4)解毒支持(包括肾功能和肝功能支持);(5)炎症调节治疗。标准手术治疗解决了前两条原则,已证明可使死亡率降低超过50%。最近一系列广泛研究报告的死亡率约为20%。腹腔间隔综合征患者(腹腔内压力超过25托)以及病情严重且有复合危险因素(以高APACHE-II评分最能说明问题)的患者适合更进阶的手术。在参与37项研究的869例患者中,单纯敞开腹部进行减压(开放式剖腹术)时,剖腹术后的死亡率为42%。在12项研究纳入的439例患者中,使用网片覆盖腹部伤口(网片剖腹术)时,死亡率为39%。接受分期腹部修复(STAR剖腹术)的患者情况较好。在11项研究的385例患者中,死亡率为28%。就降低腹腔内感染死亡率而言,目前抗生素研究以及免疫调节治疗的数据尚无定论。

相似文献

1
Operative and nonoperative therapy of intraabdominal infections.腹腔内感染的手术及非手术治疗
Infection. 1998 Sep-Oct;26(5):335-41. doi: 10.1007/BF02962267.
2
Prognostic scores and design of clinical studies.
Infection. 1998 Sep-Oct;26(5):342-4. doi: 10.1007/BF02962268.
3
Role of zipper in the management of abdominal sepsis.拉链在腹部脓毒症管理中的作用。
Indian J Gastroenterol. 1993 Jan;12(1):1-4.
4
Operative management of intraabdominal infection.
Infection. 1991 Nov-Dec;19(6):453-5. doi: 10.1007/BF01726464.
5
Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection.腹膜炎再次剖腹探查术:持续性腹腔内感染患者的预后与治疗
World J Surg. 2000 Jan;24(1):32-7. doi: 10.1007/s002689910007.
6
Epidemiology and pathophysiology of intraabdominal infections (IAI).腹腔内感染(IAI)的流行病学与病理生理学
Infection. 1998 Sep-Oct;26(5):329-34. doi: 10.1007/BF02962266.
7
Staged abdominal repair in the treatment of intra-abdominal infection: analysis of 102 patients.
J Gastrointest Surg. 2003 Jul-Aug;7(5):646-51. doi: 10.1016/s1091-255x(02)00051-3.
8
Open versus closed management of the abdomen in the surgical treatment of severe secondary peritonitis: a randomized clinical trial.严重继发性腹膜炎外科治疗中腹部开放与闭合管理的随机临床试验
Surg Infect (Larchmt). 2007 Feb;8(1):63-72. doi: 10.1089/sur.2006.8.016.
9
Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome.外科感染协会腹腔内感染研究。管理技术与结果的前瞻性评估。
Arch Surg. 1993 Feb;128(2):193-8; discussion 198-9. doi: 10.1001/archsurg.1993.01420140070011.
10
Prognosis and treatment of peritonitis. Do we need new scoring systems?腹膜炎的预后与治疗。我们是否需要新的评分系统?
Arch Surg. 1996 Feb;131(2):180-6. doi: 10.1001/archsurg.1996.01430140070019.

引用本文的文献

1
Management of intra-abdominal hypertension and abdominal compartment syndrome: a review.腹腔内高压与腹腔间隔室综合征的管理:综述
J Trauma Manag Outcomes. 2014 Feb 5;8(1):2. doi: 10.1186/1752-2897-8-2.
2
Open abdomen management: a review of its history and a proposed management algorithm.开放性腹部管理:历史回顾与管理算法建议。
Med Sci Monit. 2013 Jul 3;19:524-33. doi: 10.12659/MSM.883966.
3
Options for closure of the infected abdomen.感染性腹部的缝合选择。

本文引用的文献

1
Duration of antibiotic treatment in surgical infections of the abdomen. Forum statement: a plea for selective and controlled postoperative antibiotic administration.
Eur J Surg Suppl. 1996(576):66-9.
2
The abdominal compartment syndrome.腹腔间隔室综合征
Surg Clin North Am. 1996 Aug;76(4):833-42. doi: 10.1016/s0039-6109(05)70483-7.
3
Management of secondary peritonitis.继发性腹膜炎的管理
Ann Surg. 1996 Jul;224(1):10-8. doi: 10.1097/00000658-199607000-00003.
Surg Infect (Larchmt). 2012 Dec;13(6):343-51. doi: 10.1089/sur.2012.014. Epub 2012 Dec 10.
4
Damage control strategy for the management of perforated diverticulitis with generalized peritonitis: laparoscopic lavage and drainage vs. laparoscopic Hartmann's procedure.穿孔性憩室炎伴弥漫性腹膜炎的损伤控制性处理策略:腹腔镜灌洗引流与腹腔镜 Hartmann 手术的对比。
Surg Endosc. 2012 Oct;26(10):2835-42. doi: 10.1007/s00464-012-2255-y. Epub 2012 Apr 28.
5
Prognostic factors of the mortality of postoperative intraabdominal infections.术后腹腔内感染死亡率的预后因素。
Infection. 2010 Aug;38(4):255-60. doi: 10.1007/s15010-010-0021-4.
6
Management of enterocutaneous fistulas.小肠皮肤瘘的管理
Clin Colon Rectal Surg. 2004 May;17(2):79-88. doi: 10.1055/s-2004-828654.
7
Protein C as an early marker of severe septic complications in diffuse secondary peritonitis.蛋白C作为弥漫性继发性腹膜炎严重脓毒症并发症的早期标志物。
World J Surg. 2005 Jun;29(6):759-65. doi: 10.1007/s00268-005-7771-7.
4
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.一项比较环丙沙星加甲硝唑序贯静脉/口服治疗与亚胺培南/西司他丁治疗腹腔内感染的随机试验结果。腹腔内感染研究组。
Ann Surg. 1996 Mar;223(3):303-15. doi: 10.1097/00000658-199603000-00012.
5
Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial.美罗培南对比妥布霉素加克林霉素治疗腹腔内感染:一项前瞻性、随机、双盲临床试验的结果
Clin Infect Dis. 1995 Sep;21(3):544-50. doi: 10.1093/clinids/21.3.544.
6
Factors influencing the risk of infection after trauma.创伤后感染风险的影响因素。
Am J Surg. 1993 Feb;165(2A Suppl):2S-7S. doi: 10.1016/s0002-9610(05)81200-0.
7
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.重组人白细胞介素1受体拮抗剂治疗脓毒症综合征患者。一项随机、双盲、安慰剂对照试验的结果。III期重组人白细胞介素1受体拮抗剂脓毒症综合征研究组
JAMA. 1994 Jun 15;271(23):1836-43.
8
A burr-like device to facilitate temporary abdominal closure in planned multiple laparotomies.一种用于计划多次剖腹手术中促进临时腹部闭合的毛刺状装置。
Eur J Surg. 1993 Feb;159(2):75-9.
9
Anti-endotoxin antibodies and other inhibitors of endotoxin.抗内毒素抗体及其他内毒素抑制剂。
New Horiz. 1993 Feb;1(1):110-9.
10
The abdominal compartment syndrome: the physiological and clinical consequences of elevated intra-abdominal pressure.腹腔间隔室综合征:腹腔内压力升高的生理和临床后果。
J Am Coll Surg. 1995 Jun;180(6):745-53.